Contact details Frequently asked Questions The size: Choose region Europe Product search Keyword search news Press release 2017 / Jan / 11 In 2016, Nitto was named one of the Top 100 Innovative Companies based on patents and intellectual property - Nitto has been on the list for the sixth consecutive year 2016 / Nov / 11 Bristol-Myers Squibb signs an exclusive global licensing agreement with Nitto Denko Corporation to develop synthetic RNA for targeted therapy for advanced non-alcoholic steatohepatitis and liver cirrhosis caused by steatohepatitis 2016 / Nov / 02 Initiation of a Phase I clinical trial of a sublingual tablet with seasonal influenza hemagglutinin vaccine 2016 / Oct / 12 Nitto Denko Avecia Inc. acquires assets of Irvine Pharmaceutical Services and Avrio Biopharmaceuticals 2016 / Sep / 20 Establishment of the Basic Procurement Policy and CSR-Based Procurement Guidelines more Rss Contact / Frequently Asked Questions Contact details Frequently asked Questions Products Product by industry Product selection Product by function Product by product group Markets Automotive and transport equipment Housing and equipment for housing Infrastructure industry Production of materials Household appliances and energy industry Displays Electronic devices Medical industry Packaging industry Consumer goods About company Corporate profile Management Concepts Message from the President Rational use of natural resources Procurement Access Research and development R&D strategy and policy Basic technologies Technology-based synergy Development history Investor relations Management policies Financial data Investor Relations Archive Investor calendar Exchange and credit rating Shareholders meeting Job Topics Press release Contact details frequently asked Questions Site Map Site policy Privacy Policy © NITTO DENKO CORPORATION. 2013 All rights reserved.